Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cannabinoids
cannabinoids
Gynica to launch trial of cannabinoid-based endometriosis therapies
Clinical Trials Arena
Wed, 03/20/24 - 11:45 am
Gynica
endometriosis
clinical trials
cannabinoids
IntraVagS301
IntraVagS302
Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex
Fierce Pharma
Wed, 02/1/23 - 10:12 pm
Jazz Pharmaceuticals
Epidyolex
UK
NICE
cannabinoids
Zynerba cites 'tripledemic' for PhIII delay of a cannabinoid drug that's failed multiple times
Endpoints
Wed, 12/21/22 - 12:43 pm
Zynerba
cannabinoids
Small cannabinoid biotech gets hit with cyberattack, clinical trial delays
Endpoints
Wed, 07/20/22 - 10:23 am
Skye Bioscience
cannabinoids
cyberattacks
glaucoma
clinical trials
cybersecurity
Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US
Fierce Pharma
Tue, 06/28/22 - 10:55 am
Jazz Pharma
cannabinoids
Epidiolex
GW Pharma
Insys Eyes Sale of Opioid-Related Assets, Including Subsys
BioSpace
Sat, 11/10/18 - 12:38 pm
INSYS Therapeutics
opioids
cannabinoids
A look at The First Company Likely to Market an FDA Approved Cannabinoid in the US
CP Wire
Mon, 04/30/18 - 06:47 pm
GW Pharma
Epidiolex
FDA
cannabinoids
Israel's Therapix gets positive Tourette's drug trial results
Reuters
Tue, 04/10/18 - 09:49 am
Therapix Biosciences
clinical trials
Tourette's syndrome
cannabinoids
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
Wed, 02/21/18 - 11:00 pm
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures